Micro Emerging Active

ImmunityBio Carta de advertência da FDA

Pontuação
0,4
Velocidade
▲ 0,0
Artigos
4
Fontes
1

Resumo

Um artigo pertence a esta narrativa se ele discutir a carta de advertência da FDA recebida pela ImmunityBio.

Artigos Relacionados

ImmunityBio (IBRX) Announces NCCN Update Clinical Practice Guidelines to Include ANKTIVA for Papillary-Only NMIBC

Yahoo Finance · Mar 25, 2026
Mixed

Why ImmunityBio Stock Is Down More Than 20% Today

Yahoo Finance · Mar 24, 2026
Bearish

Fontes

Jim Cramer on ImmunityBio: “I Would Encourage You to Own … Yahoo Finance
ImmunityBio Inc. (IBRX) Receives FDA Warning Letter Over Cancer Therapy … Yahoo Finance
ImmunityBio (IBRX) Announces NCCN Update Clinical Practice Guidelines to Include … Yahoo Finance
Why ImmunityBio Stock Is Down More Than 20% Today Yahoo Finance

Cronologia

Última atualização Mar 24, 2026